Up-regulation of ATOH8 promotes the intravascular survival of CRC cells in circulation (54), and a high expression of it predicts a poor clinical outcome in patients with CRC and contributes to tumor progression. This evidence concerns the gene ATOH8 and colorectal carcinoma.